v3.26.1
Note 11 - Stock-Based Compensation - Valuation Assumptions (Details) - Lucid Diagnostics 2018 Equity Plan [Member]
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Expected term of stock options (in years) (Year) 5 years 9 months 18 days 5 years 9 months 18 days
Expected stock price volatility 67.00% 68.00%
Risk free interest rate 3.80% 4.40%